GCM
PMN icon

Gables Capital Management’s ProMIS Neurosciences PMN Stock Holding History

Gables Capital Management’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-33
Closed -$3.23K – 382
2023
Q2 		$3.23K Hold
33
– – ﹤0.01% 344
2023
Q1 		$3.94K Hold
33
– – ﹤0.01% 332
2022
Q4 		$3.62K Hold
33
– – ﹤0.01% 330
2022
Q3 		$5K Buy
+33
New +$4.86K ﹤0.01% 310

Other funds holding PMN

SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Gables Capital Management's PMN Position: Q3 2023 in Review

Gables Capital Management sold out of ProMIS Neurosciences (PMN) in Q3 2023, closing a stake of 33 shares — an estimated $3.23K sold.

Gables Capital Management first reported a position in PMN in Q3 2022 and held it in 4 quarters. The position peaked at $5K in Q3 2022. 14 funds tracked by Wall St. Rank hold PMN as of Q3 2023.

  • Gables Capital Management reported no remaining ProMIS Neurosciences position as of Q3 2023 after selling out during the quarter.
  • Gables Capital Management sold 33 ProMIS Neurosciences shares in Q3 2023, an estimated $3.23K.
  • Gables Capital Management first reported a position in ProMIS Neurosciences in Q3 2022 and held it in 4 quarters.
  • Gables Capital Management's ProMIS Neurosciences position peaked at $5K in Q3 2022.
  • 14 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q3 2023.

Based on Gables Capital Management's 13F filing for Q3 2023, filed 3 Nov 2023.